


InvVax Revenue
Biotechnology Research • Los Angeles, California, United States • 1-10 Employees
InvVax revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | $255,900 |
Key Contact at InvVax
Arthur Young
President/Founder
Company overview
| Headquarters | 570 Westwood Plaza, Los Angeles, CA 90095, US |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Vaccines |
| Founded | 2012 |
| Employees | 1-10 |
| Socials |
About InvVax
InvVax was incorporated in January 2013. Located in sunny Southern California, it maintains a strong affiliation with the UCLA, where its technology was originally developed. InvVax has access to a wide network of leading investigators in diverse disciplines, including molecular virology, immunology, pharmacology, and clinical infectious diseases. As a fledgling company, we are seeking highly talented applicants for scientific, industrial, and management roles who are interested in building a novel platform for vaccine development, and have a burning desire to make a far-ranging impact on the global human population.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
InvVax has 1 employees across 1 departments.
Departments
Number of employees
InvVax Tech Stack
Discover the technologies and tools that power InvVax's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
CDN
JavaScript libraries
Reverse proxies
Photo galleries
Font scripts
JavaScript frameworks
UI frameworks
Widgets
Font scripts
Frequently asked questions
4.8
40,000 users



